- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- December 2024
- 175 Pages
Global
From €4577EUR$5,000USD£3,890GBP
- Report
- May 2025
- 383 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 66 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 73 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 64 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 73 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 284 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 78 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 387 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 138 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 480 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 279 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 263 Pages
Global
From €5355EUR$5,850USD£4,551GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more